A novel approach to assess Lung Health
Functional Respiratory Imaging (FRI) is a imaging technology which enhances drug development and patient care by providing patient-specific parameters
A novel approach to assess Lung Health
Functional Respiratory Imaging (FRI) is a imaging technology which enhances drug development and patient care by providing patient-specific parameters
Patient-specific parameters
- 3D visualization and quantification of patient’s airway and lung geometry on a regional, often lobar, level
- Deposition characteristics of inhaled compounds
Patient-specific parameters
- 3D visualization and quantification of patient’s airway and lung geometry on a regional, often lobar, level
- Deposition characteristics of inhaled compounds
FRI benefits
Use in Clinical Trials
FRI reduces the cost and time required for screening most promising new respiratory drugs in early clinical phaseUse in Clinical Practice
FRI is sensitive and identifies more quickly inefficient therapies, improving patient careFRI benefits
Use in Clinical Trials
FRI reduces the cost and time required for screening most promising new respiratory drugs in early clinical phaseUse in Clinical Practice
FRI is sensitive and identifies more quickly inefficient therapies, improving patient care“FLUIDDA’s technique and insights to the subject were outstanding. We were delighted with the science and collaboration we had with FLUIDDA.“
Mark Milton – Edwards Global Dir. Respiratory, TEVA
“FLUIDDA’s technology is an important tool which helps bridge data from in vitro and in vivo studies.“
Dr. Paul M. Dorinsky – Head Global Respiratory Clinical Development, Cipla
“FLUIDDA’s technique and insights to the subject were outstanding. We were delighted with the science and collaboration we had with FLUIDDA.“
Mark Milton – Edwards Global Dir. Respiratory, TEVA
“FLUIDDA’s technology is an important tool which helps bridge data from in vitro and in vivo studies.“
Dr. Paul M. Dorinsky – Head Global Respiratory Clinical Development, Cipla
Esther Daemen, FLUIDDA's Quality and Training Officer and certified Data Protection Officer (DPO), will be representing us at the ‘Outsourcing
Read More
Read More
Study results will be presented at the upcoming ATS conference in Dallas on Sunday, May 19, 2:15-4:15 PM, Trinity Ballroom
Read More
Read More
Next week, Fluidda will exhibit at the annual American Thoracic Society International Conference ATS 2019 in Dallas, Texas. The ATS,
Read More
Read More
From May 7-10 the Annual Respiratory Drug Delivery Congress (RDD) will take place in Estoril, Portugal. During this conference, Fluidda
Read More
Read More
All content © FLUIDDA 2019